APA (7th ed.) Citation

H, K., C, O., SI, C., W, J., HJ, C., MA, L., . . . CK, L. (2025). Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 Quantification and Clinical Outcomes in Human Epidermal Growth Factor Receptor 2-Positive Biliary Tract Cancer Treated With Trastuzumab Plus Folinic Acid, Fluorouracil, and Oxaliplatin. JCO precision oncology, 9, e2500510. https://doi.org/10.1200/PO-25-00510

Chicago Style (17th ed.) Citation

H, Kim, et al. "Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 Quantification and Clinical Outcomes in Human Epidermal Growth Factor Receptor 2-Positive Biliary Tract Cancer Treated With Trastuzumab Plus Folinic Acid, Fluorouracil, and Oxaliplatin." JCO Precision Oncology 9 (2025): e2500510. https://doi.org/10.1200/PO-25-00510.

MLA (9th ed.) Citation

H, Kim, et al. "Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 Quantification and Clinical Outcomes in Human Epidermal Growth Factor Receptor 2-Positive Biliary Tract Cancer Treated With Trastuzumab Plus Folinic Acid, Fluorouracil, and Oxaliplatin." JCO Precision Oncology, vol. 9, 2025, p. e2500510, https://doi.org/10.1200/PO-25-00510.